Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimox2-Celecoxib Study in Metastatic Colorectal Cancer
NCT00072553Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Sep 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib in colorectal cancer (CRC), sponsored by GERCOR. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
celecoxib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00072553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072553.